Abstract
BackgroundTaurochenodeoxycholic acid (TCDCA) is one of the major active components in bile acid. It was proven to have inhibitory activities on inflammation and also participate in host immuno-regulation. TCDCA exerts anti-inflammatory and immuno-regulatory effects through the glucocorticoid receptor (GR) mediated genomic signaling pathway and the G protein-coupled bile acid receptor 5 (TGR5) mediated AC-cAMP-PKA signaling pathway. However, it is unclear whether GR or TGR5 plays an important role in the regulatory effects of TCDCA. In order to further investigate this effects mechanism of TCDCA, the research use the transcriptome to identify the major genes and pathway in the anti-inflammatory and immuno-regulatory effects.MethodsAfter the Fibroblast-like synoviocytes (FLS) being treated by different concentrations (10− 5, 10− 6 and 10− 7 M) of TCDCA for 12 h, the resulting mRNA was analyzed by RNA-seq. The differentially expressed genes were screened from sequencing results using bioinformatics techniques. In the next step, other published literature were referred in order to find out whether those genes mentioned above are related to inflammation. The final selected differentially expressed genes associated with inflammation were then validated by q-PCR and western blot assays.ResultsFive genes associated with anti-inflammatory and immuno-regulatory effects, include Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Glutathione peroxidase 3 (GPX3), Serine/arginine-rich splicing factor-9 (SRSF9), Connective tissue growth factor (CTGF) and Cystatin B (CSTB) were identified. TCDCA at the concentrations of 10− 5, 10− 6 and 10− 7 M significantly (p < 0.05) up-regulate the mRNA and protein expression of SRSF9 and GPX3 and also up-regulate the mRNA expression of CSTB, CTGF and GAPDH. RNA-seq results of GPX3 and SRSF9 expression were consistent with q-PCR results, while q-PCR results of CTGF, GAPDH showed inconsistent with their RNA-seq results. Q-PCR result of CSTB expression also showed inconsistent with the RNA-seq result.ConclusionsThe anti-inflammatory and immuno-regulatory activities of TCDCA are proven to be related to the up-regulation expression of GPX3, SRSF9 and CSTB.
Highlights
Taurochenodeoxycholic acid (TCDCA) is one of the major active components in bile acid
The results showed that mRNA expression level of Glyceraldehyde-3phosphate dehydrogenase (GAPDH) were significantly increased (p < 0.05, Fig. 9c) after treatment with TCDCA (10− 5 M, 10− 7 M) compared to the control group
In order to further investigate the major genes and pathways involved in the TCDCA relating to anti-inflammatory and immuno-regulatory effects, Fibroblast-like synoviocytes (FLS) from adjuvant arthritis (AA) rats was used in our research, and transcriptome sequencing was used for differential gene investigation
Summary
Taurochenodeoxycholic acid (TCDCA) is one of the major active components in bile acid. TCDCA exerts anti-inflammatory and immuno-regulatory effects through the glucocorticoid receptor (GR) mediated genomic signaling pathway and the G protein-coupled bile acid receptor 5 (TGR5) mediated AC-cAMP-PKA signaling pathway. It is unclear whether GR or TGR5 plays an important role in the regulatory effects of TCDCA. The anti-inflammatory action of TCDCA attributed to down regulation of the expression of LTB4, NO and PEG2 gene. It inhibits the expression of TNF-α, IL-1β and IL-6 on both mRNA and protein level in synovial tissue and plasma of adjuvant arthritis (AA) rats [3, 6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.